Order Entry
ContactUsLinkComponent
Hemoccult Ict Controls
Hemoccult® ICT Immunochemical Fecal Occult Blood Test, Beckman Coulter®
Catalog #: CA89013-352
Supplier:  Beckman Coulter
CAS Number:  
Hemoccult Ict Controls
Hemoccult® ICT Immunochemical Fecal Occult Blood Test, Beckman Coulter®
Catalog #: CA89013-352
Supplier:  Beckman Coulter
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.

Specifications

  • Description:
    Controls (two positive and two negative)
  • Cat. no.:
    CA89013-352
  • Supplier No.:
    395068A

Specifications

About this item

This immunochemical fecal occult blood test features high specificity and sensitivity, and is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based tests.

Test is CLIA waived.

  • High specificity
  • Clinically proven
  • Non-invasive

This immunochemical fecal occult blood test features high specificity and sensitivity, and is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based tests.

The superior specificity for lower gastrointestinal bleeding enables it to be an ideal screening tool for colorectal cancer and reduces the number of false positive test results. Test is safe, non-invasive, and has no diet or drug restrictions for patients to follow while they are using it, helping to increase patient compliance.

Certifications: Test is CLIA waived.
Ordering information: Patient screening kits 89013-348 are supplied with 40 patient screening kits and physician instructions. Each patient screening kit contains one dispensing envelope with patient instructions, three Hemoccult® ICT collection cards, three flushable collection tissues, three applicator sticks, and one mailing pouch. Collection cards 89013-346 are supplied with 100 cards, 100 applicator sticks, physician instructions, and sample collection instructions. Tests 89013-350 are supplied with 20 test devices, one 8mL bottle of Hemoccult® ICT Buffer, and product instructions. Tests are to be used with the collection cards and patient screening kits. Controls 89013-352 are supplied with four 0.8mL bottles (two positive and two negative) and control product instructions.
Customers Who Bought This Also Bought